BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27378946)

  • 1. Molecular and Functional Effects of a Splice Site Mutation in the MYL2 Gene Associated with Cardioskeletal Myopathy and Early Cardiac Death in Infants.
    Zhou Z; Huang W; Liang J; Szczesna-Cordary D
    Front Physiol; 2016; 7():240. PubMed ID: 27378946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
    Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
    FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
    Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
    FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional comparison of phosphomimetic S15D and T160D mutants of myosin regulatory light chain exchanged in cardiac muscle preparations of HCM and WT mice.
    Kazmierczak K; Liang J; Gomez-Guevara M; Szczesna-Cordary D
    Front Cardiovasc Med; 2022; 9():988066. PubMed ID: 36204565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
    Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
    J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy.
    Weterman MA; Barth PG; van Spaendonck-Zwarts KY; Aronica E; Poll-The BT; Brouwer OF; van Tintelen JP; Qahar Z; Bradley EJ; de Wissel M; Salviati L; Angelini C; van den Heuvel L; Thomasse YE; Backx AP; Nürnberg G; Nürnberg P; Baas F
    Brain; 2013 Jan; 136(Pt 1):282-93. PubMed ID: 23365102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
    Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
    FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.
    Karabina A; Kazmierczak K; Szczesna-Cordary D; Moore JR
    Arch Biochem Biophys; 2015 Aug; 580():14-21. PubMed ID: 26116789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
    Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
    Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of myosin light chain phosphorylation on length-dependent myosin kinetics in skinned rat myocardium.
    Pulcastro HC; Awinda PO; Breithaupt JJ; Tanner BC
    Arch Biochem Biophys; 2016 Jul; 601():56-68. PubMed ID: 26763941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of regulatory light chain mutation K104E on the ATPase and motor properties of cardiac myosin.
    Rasicci DV; Kirkland O; Moonschi FH; Wood NB; Szczesna-Cordary D; Previs MJ; Wenk JF; Campbell KS; Yengo CM
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 33891674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM.
    Kazmierczak K; Liang J; Maura LG; Scott NK; Szczesna-Cordary D
    Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory light chain phosphorylation augments length-dependent contraction in PTU-treated rats.
    Breithaupt JJ; Pulcastro HC; Awinda PO; DeWitt DC; Tanner BCW
    J Gen Physiol; 2019 Jan; 151(1):66-76. PubMed ID: 30523115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.